Purdue-affiliated startup commercializing low-cost, low-maintenance technology to better provide drinking water to schools in developing countries
/
Date29 Nov 2016
WEST LAFAYETTE, Indiana, Nov. 29, 2016 (GLOBE NEWSWIRE) — A Purdue-affiliated startup has developed a low-cost, low-maintenance slow sand water filter technology to better provide... Read More →
Pacira Pharmaceuticals and GeneAlign Announce Partnership to Develop Low-Opioid Pain Management Protocols for Postsurgical Patients at High Risk of Addiction
/
Date29 Nov 2016
PARSIPPANY, N.J., Nov. 29, 2016 (GLOBE NEWSWIRE) — Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced a joint endeavor with GeneAlign, a therapeutic management and solutions company... Read More →
Akorn Launches Ibuprofen Oral Suspension
/
Date29 Nov 2016
LAKE FOREST, Ill., Nov. 29, 2016 (GLOBE NEWSWIRE) — Akorn, Inc. (Nasdaq:AKRX), a leading specialty pharmaceutical company, today announced that it has launched the prescription... Read More →
Voyager Therapeutics and REGENXBIO Announce Exercise of Options for Rights to NAV Vectors
/
Date29 Nov 2016
CAMBRIDGE, Mass., and ROCKVILLE, Md., Nov. 29, 2016 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (NASDAQ:VYGR), a clinical-stage gene therapy company developing life-changing treatments for severe... Read More →
Dimension Therapeutics Receives Positive Opinion for European Orphan Drug Designation of DTX401 for the Treatment of Glycogen Storage Disease Type Ia (GSDIa)
/
Date29 Nov 2016
CAMBRIDGE, Mass., Nov. 29, 2016 (GLOBE NEWSWIRE) — Dimension Therapeutics, Inc. (NASDAQ:DMTX), a biopharmaceutical company advancing novel, adeno-associated virus (AAV) gene therapies targeting the liver,... Read More →
OncoMed Presents Initial First-in-Human Data for Anti-DLL4/VEGF Bispecific and Anti-RSPO3 at the 28th EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium
/
Date29 Nov 2016
Partial Responses and Stable Disease Achieved with Bispecific as a Single-Agent Safety and Target Engagement Established for Anti-RSPO3 REDWOOD CITY, Calif., Nov. 29, 2016 (GLOBE... Read More →
2bPrecise, an Allscripts company, partners with Holston Medical Group to launch early adopter genomics and precision medicine initiative
/
Date29 Nov 2016
CHICAGO, Nov. 29, 2016 (GLOBE NEWSWIRE) — 2bPrecise LLC, a wholly owned subsidiary of Allscripts Healthcare Inc. (Allscripts) (NASDAQ:MDRX), will deploy its cloud-based genomics and... Read More →
Cellular Biomedicine Group (CBMG) Approved to Commence Phase I Trial (CARD-1) for C-CAR011 in Patients with Refractory Diffuse Large B-cell Lymphoma (DLBCL) in China
/
Date29 Nov 2016
SHANGHAI, China and CUPERTINO, Calif., Nov. 29, 2016 (GLOBE NEWSWIRE) — Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biomedicine firm engaged... Read More →
Corline Biomedical AB: Renaparin® ger bättre njurfunktion i proof of priniciple-studie
/
Date29 Nov 2016
Corline Biomedical AB (“Corline”) meddelar att Renaparin® utvärderats i en preklinisk proof of principle-studie tillsammans med en forskargrupp vid Universitetet i Salamanca, Spanien. Efter transplantation... Read More →
Muutoksia Amer Sportsin rakenteessa ja johtokunnassa
/
Date29 Nov 2016
Amer Sports OyjPÖRSSITIEDOTE29.11.2016 klo 9.00 Muutoksia Amer Sportsin rakenteessa ja johtokunnassa Amer Sports jatkaa strategiansa toteuttamista digitaalisesti liitettävien laitteiden ja palveluiden kasvun kiihdyttämiseksi ja perustaa... Read More →